FDA approves Roche's Avastin for ovarian cancer

AP News
|
Posted: Nov 14, 2014 3:14 PM

NEW YORK (AP) — Swiss drugmaker Roche said Friday that the Food and Drug Administration approved its drug Avastin as a treatment for ovarian cancer.

Roche said the FDA approved Avastin in combination with chemotherapy as a treatment for recurrent cases of cancer that are resistant to platinum-based chemotherapy.

Avastin is used to treat different types of colon cancer, lung cancer, glioblastoma, kidney cancer and cervical cancer.

Recommended
Fear and Loathing of Jordan Peterson
Suzanne Fields

Roche reported $6.25 billion in revenue from the drug in 2013.